12 April 2016
A.9510 seeks to give PAs and NPs marijuana prescribing power, and to certify patients for the program. In New York, these types of health professionals currently have the power to prescribe “the strongest and most dangerous controlled substances,” Gottfried said in a press release, referring to opioid-based pharmaceuticals.
A.9562, which carries a same-as version in the State Senate championed by Diane Savino (D), seeks to remove the dosing limit and add Alzheimer’s disease, traumatic brain injury, dystonia, muscular dystrophy, wasting syndrome, post-traumatic stress disorder, rheumatoid arthritis, and lupus to the list of the program’s treatable conditions. The conditions were removed before the bill’s passage.
Under A.9553 an advisory committee would be created to help advise the health commissioner in matters of patient and caregiver appeals and program recommendations. According to the bill text, the committee would consist of healthcare practitioners, patients or patient representatives, controlled substance regulation experts, medical marijuana industry professionals, and members from the law enforcement community. The bill would also allow for medical marijuana patients in other states to have their needs met in New York.